
    
      The purpose of this study is to comparethe efficacy and safety Ophthalmic Solution in
      combination with Latanoprost when the therapy is swiched from Latanoprost monotherapy in
      patient with Glaucoma or ocular hypertension.

      The study will be open label, prospective, multi-centered where patients will be swiched from
      Latanoprostmonotherapy to a combination therapy of Latanoprost with Combigan Ophthalmic
      Solution.
    
  